Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,499 | -5,260 | -3,967 | -5,760 | -2,970 |
| Depreciation Amortization | 1,325 | 393 | 561 | 590 | 320 |
| Accounts receivable | -90 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -741 | -96 | 60 | N/A | N/A |
| Other Working Capital | -1,355 | 1,722 | 503 | 290 | N/A |
| Other Operating Activity | 2,361 | -120 | 190 | -130 | -470 |
| Operating Cash Flow | $-7,999 | $-3,363 | $-2,655 | $-5,010 | $-3,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -333 | -134 | -335 | -510 | N/A |
| Net Acquisitions | 356 | N/A | N/A | 0 | N/A |
| Purchase Sale Intangibles | -361 | -51 | -145 | N/A | N/A |
| Other Investing Activity | -964 | -1,085 | -145 | 3,590 | -2,760 |
| Investing Cash Flow | $-941 | $-1,218 | $-480 | $3,080 | $-2,760 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -180 | -116 | -136 | N/A | N/A |
| Common Stock Issued | 10,048 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,188 | 4,236 | 3,561 | 1,030 | 50 |
| Financing Cash Flow | $11,057 | $4,120 | $3,425 | $1,030 | $50 |
| Exchange Rate Effect | -395 | 29 | -108 | 0 | N/A |
| Beginning Cash Position | 243 | 675 | 492 | 3,740 | 9,570 |
| End Cash Position | 1,965 | 243 | 675 | 2,850 | 3,740 |
| Net Cash Flow | $1,722 | $-431 | $182 | $-890 | $-5,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,999 | -3,363 | -2,655 | -5,010 | -3,120 |
| Capital Expenditure | -425 | -134 | -424 | N/A | N/A |
| Free Cash Flow | -8,424 | -3,496 | -3,079 | -5,010 | -3,120 |